The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Lactobacillus rhamnosus bacteremia: an emerging clinical entity
Abstract
Lactobacillus spp. are ubiquitous commensals of the normal human flora that are only occasionally found in clinical infections. Their role in human disease is established for infectious endocarditis but is controversial for other infections. We sought to characterize clinically associated Lactobacillus spp. We conducted a retrospective study, which consisted of the screening of Lactobacillus isolates obtained in our laboratory from January 2004 to December 2009. The polymerase chain reaction (PCR) assay was selected as the gold standard method. The isolates were first identified using API Coryne strips, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), and 16S rRNA gene sequencing. Lactobacillus tuf gene-based identification was used when the 16S rRNA results were inconclusive. Among the 60 strains of Lactobacillus spp. obtained in our laboratory, L. rhamnosus was the most commonly isolated species and was found in blood cultures from 16 patients. Combined with 45 patients reported in the literature, we found that patients presenting with L. rhamnosus bacteremia experienced nosocomial infections associated with both immunosuppression (66 %) and catheters (83 %).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common species isolated from LB blood samples is Lcb. rhamnosus GG (ATCC53103) [6,7,15,22,23,24].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [24]
In the citing paper
“Our review also revealed 49 case reports of LB without any history of probiotic use (Table 1) [24,26,27,33,35,45,46,47,48,49,50,51].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [24]
Citations
Cites
Janda, J. M., & Abbott, S. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01228-07 · Cited by 2,216 · cited 1×
“Introduction Microbial identification methods using 16S rRNA gene sequencing, which have increased by 456 % in 15 years, have enhanced the recognition of new bacterial species [1].”
Seng, P., Drancourt, M., Gouriet, F., La Scola, B., Fournier, P., Rolain, J. M., & Raoult, D. (2009) · Clinical Infectious Diseases · doi:10.1086/600885 · Cited by 1,983 · cited 2×
“More recently, matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDITOF MS) has been added as a rapid identification tool [2, 3].”
Self-citationBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Drancourt, M., Bollet, C., Carlioz, A., Martelin, R., Gayral, J.-P., & Raoult, D. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3623-3630.2000 · Cited by 1,103 · cited 1×
“obtained from the clinical specimens, 16S rRNA gene-based identifications were performed as previously described [9].”
Self-citationSafety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816 · cited 1×
“Probiotic supplementation must be used with caution in individuals who may be at risk for the dissemination of these live microbes to sterile sites [58].”
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“rhamnosus infection in the literature [10–45].”
Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases
Cannon, J. P., Lee, T. A., Bolanos, J. T., & Danziger, L. H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1253-y · Cited by 478 · cited 3×
“have occasionally been associated with serious infections, especially among immunocompromised patients and those suffering from endocarditis [4].”
InfluentialThe normal Lactobacillus flora of healthy human rectal and oral mucosa
Ahrné, Nobaek, Jeppsson, Adlerberth, Wold, & Molin (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.00480.x · Cited by 439 · cited 2×
“rhamnosus specifically belongs to the normal flora of healthy human rectal, oral [46], and vaginal mucosa [47].”
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 1×
“rhamnosus-associated bacteremia, the reported mortality rate ranges from 12 to 48 %, depending on the treatment [54, 55].”
Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419 · cited 2×
“4 % of cases of infective endocarditis and bacteremia [5].”
Research works printed but not linked: 1
- Biller JA, Katz AJ, Flores AF et al (1995) Treatment of recurrent v colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 21:224–226 · doi:10.1097/00005176-199508000-00016 · Paper page
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Antibiotic resistance in probiotic bacteria
Gueimonde, M., Sánchez, B., G. de los Reyes-Gavilán, C., & Margolles, A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00202 · Cited by 691
“Those probiotics belonging to species included in the EFSA QPS list (EFSA, 2012) have excellent safety records, and detrimental effects produced as a consequence of their ingestion are very scarce (Gouriet et al., 2012).”
BackgroundInfluentialSeng, P., Abat, C., Rolain, J. M., Colson, P., Lagier, J.-C., Gouriet, F., Fournier, P. E., Drancourt, M., La Scola, B., & Raoult, D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00492-13 · Cited by 438
Self-citationPlaza-Díaz, J., Ruiz-Ojeda, F., Vilchez-Padial, L., & Gil, A. (2017) · Nutrients · doi:10.3390/nu9060555 · Cited by 423
“Therefore, although probiotics can offer potential benefits in certain healthy conditions, their risks and benefits should still be carefully assessed in patients with some complications, especially when the patients might be immunocompromised [69,70].”
BackgroundLactobacillus species: Taxonomic complexity and controversial susceptibilities
Goldstein, E. J. C., Tyrrell, K. L., & Citron, D. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ072 · Cited by 392
“rhamnosus [8, 12, 13] L.”
Metadata
- Authors
- Gouriet, F., Million, M., Henri, M., Fournier, P.-E., & Raoult, D.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Raoult, D.
- Venue
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2012-04-28
- Volume
- 31
- Issue
- 9
- Pages
- 2469-2480
- ISSN
- 0934-9723 (ISSN-L)
- 1435-4373
- OpenAlex
- W2007838481
- Cited by
- 93
- References
- 59
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 2 · 2023: 9 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 11 · 2018: 6 · 2017: 13 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 1
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Lactobacillus rhamnosus, bacteremia, nosocomial infections, catheter-related infection, immunosuppression, blood culture isolates, MALDI-TOF mass spectrometry, 16S rRNA gene sequencing
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Male, Middle Aged, Retrospective Studies, RNA, Ribosomal, 16S, Polymerase Chain Reaction, Bacteremia, Gram-Positive Bacterial Infections, Sequence Analysis, DNA, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Communicable Diseases, Emerging, Lacticaseibacillus rhamnosus, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactobacillus rhamnosus bacteremia: an emerging clinical entity. https://app.cochat.ai/papers/10.1007/s10096-012-1599-5
- The paper
- Gouriet, F., Million, M., Henri, M., Fournier, P.-E., & Raoult, D. (2012). Lactobacillus rhamnosus bacteremia: an emerging clinical entity. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-012-1599-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.